ResMed | RMD - Cash And Equivalent

Stock Price
267.42
Daily Change
4.39 1.67%
Monthly
7.32%
Yearly
12.75%
Q1 Forecast
250.35

ResMed reported $1.42B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Ansell USD 238.3M 674M Jun/2025
AtriCure USD 147.86M 30.07M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Cochlear AUD 275.7M 107.4M Jun/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
CSL USD 2.16B 633M Jun/2025
Dexcom USD 1.84B 676.7M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Fisher Paykel Healthcare NZD 89.9M 13.3M Jun/2022
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Idexx Laboratories USD 208.17M 43.57M Sep/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Philips EUR 1.91B 90M Sep/2025
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
ResMed USD 1.42B 33.22M Dec/2025
Sigma Healthcare AUD 16.65M 3.68M Jan/2023
Sonic Healthcare AUD 645M 25.39M Jun/2024
Steris USD 423.7M 104.5M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025